Ryne Biotechnology announced it raised $30 Million in an initial filing from an offering of $81.8 Million

Company

Location

About

Kenai Therapeutics is also known as Ryne Biotechnology. Ryne Bio is a biotechnology company pioneering next-generation approaches to cure neurological disorders. The company utilizes induced pluripotent stem cell (iPSC) technology, a Nobel-winning breakthrough that enables scientists to manufacture any human cell, in order to advance Ryne Bio’s off-the-shelf neuron replacement therapeutics. By focusing on an iPSC technology platform, and forging partnerships with global leaders in surgical delivery and clinical development, Ryne Bio is dedicated to advancing a best-in-class pipeline targeting neurological diseases.